Literature DB >> 2837732

Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen.

M J Allday1, D H Crawford, B E Griffin.   

Abstract

The protein sequence predicted by the Epstein Barr virus (EBV) BERF4 open reading frame includes a tetrapeptide, Lys-Arg-Pro-Arg (KRPR), shown for other proteins to be a component of a signal for rapid nuclear localization. A subgenomic fragment of EBV DNA containing BERF4 has been incorporated into an expression vector, transfected onto primate cells and the nuclear distribution of the resulting protein established by immunofluorescence using EBV positive human sera. These sera contained high titres of antibodies to a fusion protein, produced in E. coli, consisting of beta-galactosidase and the C-terminal 167 amino acids of BERF4. Immunoaffinity purified antibodies reactive with the EBV component of the fusion show the molecular weight of this antigen in EBV immortalized B-cell lines to be about 160 kD. The demonstration that BERF4 contains an exon encoding a nuclear protein identifies a new EBNA gene (EBNA-6) and suggests that KRPR is a signal sequence common to a number of viral and cellular nuclear polypeptides which bind to nucleic acids and may therefore be of predictive value in identifying karyophilic proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837732      PMCID: PMC336635          DOI: 10.1093/nar/16.10.4353

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

2.  A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.

Authors:  D Reisman; J Yates; B Sugden
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

3.  Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus.

Authors:  D T Rowe; P J Farrell; G Miller
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

4.  Epstein-Barr virus mRNAs produced by alternative splicing.

Authors:  M Bodescot; M Perricaudet
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

5.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

6.  Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.

Authors:  Y Hinuma; J T Grace
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

9.  An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.

Authors:  J Dillner; B Kallin; H Alexander; I Ernberg; M Uno; Y Ono; G Klein; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

View more
  12 in total

1.  Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

Authors:  S A Radkov; M Bain; P J Farrell; M West; M Rowe; M J Allday
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.

Authors:  M Bain; R J Watson; P J Farrell; M J Allday
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  cDNA cloning and transient expression of the Epstein-Barr virus-determined nuclear antigen EBNA3B in human cells and identification of novel transcripts from its coding region.

Authors:  B Kerdiles; D Walls; H Triki; M Perricaudet; I Joab
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Transport of hepatitis B virus precore protein into the nucleus after cleavage of its signal peptide.

Authors:  J H Ou; C T Yeh; T S Yen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

Authors:  M Rowe; L S Young; K Cadwallader; L Petti; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.

Authors:  Pankaj Kumar; Masanao Murakami; Rajeev Kaul; Abhik Saha; Qiliang Cai; Erle S Robertson
Journal:  Future Virol       Date:  2009-01       Impact factor: 1.831

7.  The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport.

Authors:  C T Yeh; Y F Liaw; J H Ou
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Occupancy of chromatin organizers in the Epstein-Barr virus genome.

Authors:  Meghan M Holdorf; Samantha B Cooper; Keith R Yamamoto; J J L Miranda
Journal:  Virology       Date:  2011-05-08       Impact factor: 3.616

9.  Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells.

Authors:  M J Allday; P J Farrell
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.

Authors:  S A Radkov; R Touitou; A Brehm; M Rowe; M West; T Kouzarides; M J Allday
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.